Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer

被引：1
|
作者：
Thomae, Keith
Sargent
Russell, Christy A.
Russell
机构：
来源：
AMERICAN JOURNAL OF SURGERY | 2022年 / 223卷 / 03期
关键词：
D O I：
10.1016/j.amjsurg.2022.02.025
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center
    Sargent, Rachel E.
    Vazquez, Elizabeth
    Kang, Irene
    Lu, Janice
    Manchandia, Tejas
    Sheth, Pulin
    Terando, Alicia
    Nelson, Maria E.
    Carr, Azadeh
    Hong, David S.
    Sener, Stephen F.
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 539 - 542
  • [2] Early relapse and predictors of relapse-free survival in neoadjuvant chemotherapy-treated breast cancer patients
    Martin, Natalie
    Pasztorova, Julia
    Hibell, Isabella
    Wheatley, Duncan
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [3] Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy
    Li, JunJie
    Chen, Sheng
    Chen, CanMing
    Di, GenHong
    Liu, GuangYu
    Wu, Jiong
    Shao, ZhiMin
    [J]. ONCOTARGET, 2017, 8 (11) : 18399 - 18408
  • [4] Changes of topoisomerase IIα expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival
    Tinari, N
    Lattanzio, R
    Natoli, C
    Cianchetti, E
    Angelucci, D
    Ricevuto, E
    Ficorella, C
    Marchetti, P
    Alberti, S
    Piantelli, M
    Iacobelli, S
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (05) : 1501 - 1506
  • [5] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xionan
    Lin, Juan
    Condeelis, John S.
    Sparanno, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [6] Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival
    Billgren, AM
    Rutqvist, LE
    Tani, E
    Wilking, N
    Fornander, T
    Skoog, L
    [J]. ACTA ONCOLOGICA, 1999, 38 (05) : 597 - 601
  • [7] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy.
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xiaonan
    Lin, Juan
    Condeelis, John S.
    Sparano, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 102 - 103
  • [8] Clusterin Overexpression and Relapse-free Survival in Breast Cancer
    Yom, Cha Kyong
    Woo, Hee-Yeon
    Min, Sun Young
    Kang, So Young
    Kim, Hee Sung
    [J]. ANTICANCER RESEARCH, 2009, 29 (10) : 3909 - 3912
  • [9] Clinical and pathological factors related to brain relapse-free survival in breast cancer patients
    Altundag, Kadri
    [J]. HUMAN PATHOLOGY, 2017, 69 : 141 - 142
  • [10] Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer
    Van Laere, Steven
    Beissbarth, Tim
    Van der Auwera, Ilse
    Van den Eynden, Gert
    Trinh, Xuan Bich
    Elst, Hilde
    Van Hummelen, Paul
    van Dam, Peter
    Van Marck, Eric
    Vermeulen, Peter
    Dirix, Luc
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (22) : 7452 - 7460
12345